ArticlePLoS pathogens2026
Aerobactin is a key driver of hypervirulent Klebsiella pneumoniae translocation and virulence.
Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sugar import suppresses Klebsiella pneumoniae Mucoidy in a cAMP-CRP-dependent manner.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Hypervirulent Klebsiella pneumoniae (hvKP) is an emerging pathotype capable of causing severe systemic infections. Gastrointestinal (GI) colonization often precedes invasive disease, but the mechanisms driving translocation to extra-intestinal sites are not known. A hallmark of hvKP is a large virulence plasmid encoding a number of virulence factors, including aerobactin, a siderophore associated with enhanced virulence. Using a murine GI colonization model with an intact microbiota, we examined if aerobactin enabled hvKP to translocate, by comparing an hvKP clinical isolate (hvKP1) to an isogenic aerobactin biosynthesis mutant (iucA-). Both strains colonized the GI tract similarly, but mice colonized with the iucA- mutant exhibited significantly lower bacterial burdens in the extra-intestinal organs, indicating a defect in translocation. This defect was not observed in a systemic infection model, suggesting a specific role for aerobactin in GI translocation. In cell culture based assays, the iucA- mutant showed reduced adhesion, invasion, and translocation. Both in vivo and in vitro data supported a transcellular route of translocation. Notably, the iucA- mutant displayed increased hypermucoviscosity (HMV) linked to the upregulation of the rmp locus, likely impairing host cell adhesion. These findings demonstrate that tight regulation of HMV through metal homeostasis mediated by aerobactin, promotes hvKP translocation across the intestinal epithelium by enhancing adhesion and cellular entry. This work offers new insight into hvKP pathogenesis and informs potential strategies to limit its invasive potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.